Sectors

CAPR
Capricor Therapeutics, Inc.
9.91
1 x 8.75
2 x 11.68
bid
ask
+
0.32
3.34%
2 @ 07:59 PM
9.91 +0.00 (0.01%)
Ytd-65.66%
1y57.80%
9.06
day range
10.23
2.96
52 week range
40.37
Open9.41Prev Close9.59Low9.06High10.23Mkt Cap576.16M
Vol4.56MAvg Vol5.90MEPS-2.45P/EN/AForward P/E-35.03
Beta0.42Short Ratio13.95Inst. Own59.73%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-1050-d Avg14.56200-d Avg23.271yr Est53.60

CAPR News

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit
prnewswire.com
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit

NEW YORK, Aug. 31, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, remi

SEPTEMBER 28, 2026 CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
newsfilecorp.com
SEPTEMBER 28, 2026 CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Lo

San Diego, California--(Newsfile Corp. - August 31, 2026) - The law firm of Robbins Geller Rudman &

Deadline Alert: Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
globenewswire.com
Deadline Alert: Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Urged To Contact Glan

LOS ANGELES, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors o

Kaplan Fox Advises Capricor Therapeutics, Inc. (CAPR) Investors of a Securities Class Action Deadline on September 28, 2026
newsfilecorp.com
Kaplan Fox Advises Capricor Therapeutics, Inc. (CAPR) Investors of a Securities Class Action Deadlin

New York, New York--(Newsfile Corp. - August 31, 2026) - Kaplan Fox & Kilsheimer LLP announces that

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
newsfilecorp.com
Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsu

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 31, 2026) - Kahn Swick & Fot

CAPR Shareholder Alert: Capricor Therapeutics, Inc. Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky
globenewswire.com
CAPR Shareholder Alert: Capricor Therapeutics, Inc. Securities Class Action Lawsuit - Investors Shou

A securities class action alleges Capricor Therapeutics told investors its Deramiocel application wa

Hagens Berman Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to FDA Review Extension for Deramiocel Amid Ongoing Securities Class Action and September 28 Lead Plaintiff Deadline
globenewswire.com
Hagens Berman Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to FDA Review Extension fo

SAN FRANCISCO, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP—a national plaintif

Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Capricor Therapeutics, Inc. (NASDAQ: CAPR) on September 28, 2026
globenewswire.com
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Capric

NEW YORK, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class actio

CAPR Investment Losses: Capricor Therapeutics Clinical Data Announcement Leads to 64% Stock Drop – BFA Law Reminds Investors of the Pending Securities Fraud Class Action
globenewswire.com
CAPR Investment Losses: Capricor Therapeutics Clinical Data Announcement Leads to 64% Stock Drop – B

Capricor Therapeutics, Inc. has been sued for securities fraud over alleged misstatements about Dera

Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR
prnewswire.com
Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discus

LOS ANGELES, Aug. 31, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action law

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
prnewswire.com
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SB

LOS ANGELES, Aug. 31, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national sharehol

CAPR CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 28, 2026
newsfilecorp.com
CAPR CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR
newsfilecorp.com
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel B

New York, New York--(Newsfile Corp. - August 30, 2026) - WHY: Rosen Law Firm, a global investor righ

Kessler Topaz Meltzer & Check, LLP - INVESTOR DEADLINE ALERT: Capricor Therapeutics, Inc. (CAPR) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
globenewswire.com
Kessler Topaz Meltzer & Check, LLP - INVESTOR DEADLINE ALERT: Capricor Therapeutics, Inc. (CAPR) Inv

Did you buy CAPR securities between December 17, 2025 and July 26, 2026 ? Affected CAPR Investor Sum

Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action F

New class action for Capricor (CAPR) urges investors to seek recovery for alleged securities fraud v

ROSEN, A LONGSTANDING FIRM, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR
globenewswire.com
ROSEN, A LONGSTANDING FIRM, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Befor

NEW YORK, Aug. 29, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
gurufocus.com
Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsu

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsu

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
prnewswire.com
Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsu

/PRNewswire/ -- Kahn Swick and Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisia

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
newsfilecorp.com
Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsu

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 28, 2026) - Kahn Swick & Fot

Kaplan Fox Notifies Investors of Capricor Therapeutics, Inc. (CAPR) of a Securities Fraud Class Action Deadline on September 28, 2026
newsfilecorp.com
Kaplan Fox Notifies Investors of Capricor Therapeutics, Inc. (CAPR) of a Securities Fraud Class Acti

New York, New York--(Newsfile Corp. - August 28, 2026) - Kaplan Fox & Kilsheimer LLP announces that

Hagens Berman Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to FDA Review Extension for Deramiocel Amid Ongoing Securities Class Action and September 28 Lead Plaintiff Deadline
gurufocus.com
Hagens Berman Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to FDA Review Extension fo

Hagens Berman Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to FDA Review Extension fo

Hagens Berman Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to FDA Review Extension for Deramiocel Amid Ongoing Securities Class Action and September 28 Lead Plaintiff Deadline
prnewswire.com
Hagens Berman Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to FDA Review Extension fo

SAN FRANCISCO, Aug. 28, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP—a national plaintiffs'

Kaplan Fox Reminds Investors of a Securities Class Action Against Capricor Therapeutics, Inc. (NASDAQ: CAPR) – Deadline is September 28, 2026
globenewswire.com
Kaplan Fox Reminds Investors of a Securities Class Action Against Capricor Therapeutics, Inc. (NASDA

Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Th

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
globenewswire.com
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SB

LOS ANGELES, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shar

Capricor Therapeutics, Inc. (CAPR) Securities Fraud: Contact Berger Montague To Discuss Your Rights
newsfilecorp.com
Capricor Therapeutics, Inc. (CAPR) Securities Fraud: Contact Berger Montague To Discuss Your Rights

Philadelphia, Pennsylvania--(Newsfile Corp. - August 28, 2026) - National plaintiffs' law firm Berge

CAPR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 28, 2026
newsfilecorp.com
CAPR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Cl

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff

Investor Notice: Capricor Therapeutics (NASDAQ:CAPR) Accused of Misleading Investors in Securities Fraud Class Action – Contact BFA Law if You Lost Money
globenewswire.com
Investor Notice: Capricor Therapeutics (NASDAQ:CAPR) Accused of Misleading Investors in Securities F

NEW YORK, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP a

ROSEN, A NATIONALLY RECOGNIZED LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR
newsfilecorp.com
ROSEN, A NATIONALLY RECOGNIZED LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors to Secure

New York, New York--(Newsfile Corp. - August 27, 2026) - WHY: Rosen Law Firm, a global investor righ

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - CAPR
prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor The

NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been

DEADLINE ALERT for RXT, CAPR, BE, PRCT: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions
globenewswire.com
DEADLINE ALERT for RXT, CAPR, BE, PRCT: Law Offices of Howard G. Smith Reminds Investors of Opportun

BENSALEM, Pa., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors th

Kaplan Fox Reminds Investors of Capricor Therapeutics, Inc. (CAPR) to a Securities Class Action Deadline - Contact the Firm Before September 28, 2026
newsfilecorp.com
Kaplan Fox Reminds Investors of Capricor Therapeutics, Inc. (CAPR) to a Securities Class Action Dead

New York, New York--(Newsfile Corp. - August 27, 2026) - Kaplan Fox & Kilsheimer LLP announces that

Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR
globenewswire.com
Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100

NEW ORLEANS, Aug. 27, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service,

CAPR DEADLINE: SueWallSt Reminds Capricor Therapeutics, Inc. Investors of Upcoming Securities Class Action Deadline
prnewswire.com
CAPR DEADLINE: SueWallSt Reminds Capricor Therapeutics, Inc. Investors of Upcoming Securities Class

Capricor's Chief Executive Officer and Chief Financial Officer are named as individual defendants in

CAPR Stock Alert: Capricor Therapeutics, Inc. Reports Q2 Earnings Amid Ongoing Securities Class Action Lawsuit - Hagens Berman
newsfilecorp.com
CAPR Stock Alert: Capricor Therapeutics, Inc. Reports Q2 Earnings Amid Ongoing Securities Class Acti

San Francisco, California--(Newsfile Corp. - August 27, 2026) - National investor rights law firm Ha

Capricor Therapeutics, Inc. (CAPR) Class Action Lawsuit Seeks Recovery for Investors; September 28, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP
prnewswire.com
Capricor Therapeutics, Inc. (CAPR) Class Action Lawsuit Seeks Recovery for Investors; September 28,

Did you buy CAPR securities between December 17, 2025 and July 26, 2026? Affected CAPR Investor Summ

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
gurufocus.com
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SB

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SB

Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR
gurufocus.com
Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discus

Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discus

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
prnewswire.com
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SB

LOS ANGELES, Aug. 27, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national sharehol

Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR
prnewswire.com
Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discus

LOS ANGELES, Aug. 27, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action law

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
newsfilecorp.com
Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsu

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 26, 2026) - Kahn Swick & Fot

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR
newsfilecorp.com
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Be

New York, New York--(Newsfile Corp. - August 26, 2026) - WHY: Rosen Law Firm, a global investor righ

CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
prnewswire.com
CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportuni

SAN FRANCISCO, Aug. 26, 2026 /PRNewswire/ -- National investor rights law firm Hagens Berman highlig

Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. and Encourages Investors to Contact the Firm
globenewswire.com
Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Cap

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered L

Kaplan Fox Reminds Investors of Capricor Therapeutics, Inc. (CAPR) to a Securities Class Action Deadline - Contact the Firm Before September 28, 2026
newsfilecorp.com
Kaplan Fox Reminds Investors of Capricor Therapeutics, Inc. (CAPR) to a Securities Class Action Dead

New York, New York--(Newsfile Corp. - August 26, 2026) - Kaplan Fox & Kilsheimer LLP announces that

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers Biohaven (NYSE:BHVN) shares increased by 16.5% to $16.75 during Wednesday's regular ses

Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action F

New class action for Capricor (CAPR) urges investors to seek recovery for alleged securities fraud v

Abercrombie & Fitch Posts Upbeat Q2 Results, Joins Semtech, Summit Therapeutics And Other Big Stocks Moving Higher On Wednesday
benzinga.com
Abercrombie & Fitch Posts Upbeat Q2 Results, Joins Semtech, Summit Therapeutics And Other Big Stocks

U.S. stocks mixed, Nasdaq up 0.1%. Abercrombie & Fitch shares surge 31.6% after beating earnings

CAPR Shareholder Alert: Capricor Therapeutics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky
prnewswire.com
CAPR Shareholder Alert: Capricor Therapeutics, Inc. Securities Class Action Lawsuit - Investors With

A securities class action alleges Capricor Therapeutics failed to disclose that it changed the pre-s

Faruqi & Faruqi, LLP Urges Capricor Therapeutics, Inc. (CAPR) Investors to Seek Counsel Before the September 28, 2026 Lead Plaintiff Deadline in the Securities Class Action
newsfilecorp.com
Faruqi & Faruqi, LLP Urges Capricor Therapeutics, Inc. (CAPR) Investors to Seek Counsel Before the S

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff

Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026 for a Leadership Role
globenewswire.com
Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Befor

Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Th